Ruth A. Keri

6.6k citations

92 papers · 4.3k indexed · h-index 37

Molecular Biology top 5%
Genetics top 2%
Oncology top 5%
Cancer Research top 2%
Health, Toxicology and Mutagenesis top 2%

Co-authors: John H. Nilson Darcie D. Seachrist Gail S. Prins Shuk‐Mei Ho Ana M. Soto Fadi W. Abdul‐Karim Kristen L. Lozada Steven T. Sizemore
Topics: Cancer Cells and Metastasis (14 papers)Ubiquitin and proteasome pathways (9 papers)Animal Genetics and Reproduction (9 papers)
Cited by: Reproductive Medicine Cancer Research Health, Toxicology and Mutagenesis
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: United States Australia Finland

In The Last Decade

Ruth A. Keri

91 papers receiving 4.3k citations

Peers

Countries citing papers authored by Ruth A. Keri

Since Specialization

Citations

This map shows the geographic impact of Ruth A. Keri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth A. Keri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth A. Keri more than expected).

Fields of papers citing papers by Ruth A. Keri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth A. Keri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth A. Keri. The network helps show where Ruth A. Keri may publish in the future.

Co-authorship network of co-authors of Ruth A. Keri

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth A. Keri. A scholar is included among the top collaborators of Ruth A. Keri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth A. Keri. Ruth A. Keri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploiting YES1-Driven EGFR Expression Improves the Efficacy of EGFR Inhibitors 2025 ·Molecular Cancer Research ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Fadi W. Abdul‐Karim,Christine N. Booth,Ruth A. Keri	1
2	The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer 2024 ·Cell Death and Differentiation ·(unknown),(unknown),Darcie D. Seachrist,(unknown),(unknown),Zhenghao Liu,Ruth A. Keri,Kaixiang Cao,William P. Schiemann,Hung‐Ying Kao	5
3	MR Molecular Image Guided Treatment of Pancreatic Cancer with Targeted ECO/miR-200c Nanoparticles in Immunocompetent Mouse Tumor Models 2024 ·Pharmaceutical Research ·(unknown),Ryan Hall,Xueer Yuan,(unknown),(unknown),(unknown),(unknown),Suneel Apte,Jordan M. Winter,Ruth A. Keri,Zheng‐Rong Lu	4
4	TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis 2023 ·Cancer Research ·Lindsey J. Anstine,(unknown),(unknown),Salendra Singh,(unknown),(unknown),Fadi W. Abdul‐Karim,(unknown),Darcie D. Seachrist,(unknown),(unknown),Gina M. Sizemore,Steven T. Sizemore,Bryan M. Webb,Cheryl L. Thompson,Ruth A. Keri	3
5	Spatial Transcriptomics Suggests That Alterations Occur in the Preneoplastic Breast Microenvironment of BRCA1 / 2 Mutation Carriers 2023 ·Molecular Cancer Research ·Anthony Caputo,(unknown),Peter Bazeley,(unknown),Patrick J. McIntire,(unknown),Ying Ni,Bo Hu,Ruth A. Keri,Mihriban Karaayvaz	4
6	Disruption of CDK7 signaling leads to catastrophic chromosomal instability coupled with a loss of condensin-mediated chromatin compaction 2023 ·Journal of Biological Chemistry ·(unknown),Bryan M. Webb,(unknown),(unknown),(unknown),Benjamin L. Bryson,(unknown),Darcie D. Seachrist,Ruth A. Keri	6
7	TGF-β/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters 2021 ·Journal of Biological Chemistry ·Bryan M. Webb,Benjamin L. Bryson,(unknown),(unknown),Darcie D. Seachrist,Lindsey J. Anstine,Ruth A. Keri	9
8	LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance 2020 ·Cancer Research ·(unknown),(unknown),Morgan S. Schrock,(unknown),(unknown),Darcie D. Seachrist,Stefanie Avril,Lindsey J. Anstine,Salendra Singh,Steven T. Sizemore,Vinay Varadan,Matthew K. Summers,Ruth A. Keri	29
9	JAM-A functions as a female microglial tumor suppressor in glioblastoma 2020 ·Neuro-Oncology ·Soumya M. Turaga,Daniel J. Silver,Defne Bayık,Evi Paouri,Sen Peng,Adam Lauko,Tyler Alban,(unknown),(unknown),Ulhas P. Naik,Ruth A. Keri,James R. Connor,Jill S. Barnholtz‐Sloan,Joshua B. Rubin,Michael E. Berens,Dimitrios Davalos,Justin D. Lathia	28
10	KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene 2020 ·Breast Cancer Research ·(unknown),Lindsey J. Anstine,(unknown),Benjamin L. Bryson,Bryan M. Webb,(unknown),Darcie D. Seachrist,(unknown),Ruth A. Keri	20
11	The membrane tethered matrix metalloproteinase MT1-MMP triggers an outside-in DNA damage response that impacts chemo- and radiotherapy responses of breast cancer 2018 ·Cancer Letters ·Varsha Thakur,Keman Zhang,(unknown),(unknown),Brittany Aguila,Scott M. Welford,Fadi W. Abdul‐Karim,(unknown),Ruth A. Keri,Barbara Bedogni	19
12	Targeting bromodomain and extraterminal proteins in breast cancer 2017 ·Pharmacological Research ·(unknown),Ruth A. Keri	44
13	Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression 2014 ·Cancer Research ·(unknown),Kristen L. Lozada,Darcie D. Seachrist,Jonathan D. Mosley,Fadi W. Abdul‐Karim,Christine N. Booth,Chris A. Flask,Ruth A. Keri	34
14	Aberrant expression of LMO4 induces centrosome amplification and mitotic spindle abnormalities in breast cancer cells 2010 ·The Journal of Pathology ·(unknown),Melissa D. Shelton,Darcie D. Seachrist,Kristen L. Lozada,Emhonta Johnson,John D. Miedler,Fadi W. Abdul‐Karim,Jane E. Visvader,Ruth A. Keri	18
15	Increases in luteinizing hormone are associated with declines in cognitive performance 2007 ·Molecular and Cellular Endocrinology ·Gemma Casadesús,Erin L. Milliken,Kate M. Webber,Richard L. Bowen,Zhenmin Lei,Ch.V. Rao,George Perry,Ruth A. Keri,Mark A. Smith	87
16	Signaling through 3′,5′-Cyclic Adenosine Monophosphate and Phosphoinositide-3 Kinase Induces Sodium/Iodide Symporter Expression in Breast Cancer 2004 ·The Journal of Clinical Endocrinology & Metabolism ·Katherine A. B. Knostman,Je‐Yoel Cho,Kwon‐Yul Ryu,Xiaoqin Lin,James A. McCubrey,Timothy Hla,Catherine H. Liu,Emma Di Carlo,Ruth A. Keri,Ming Zhang,Dae Youn Hwang,William C. Kisseberth,Charles C. Capen,Sissy Jhiang	22
17	Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion 2003 ·American Journal of Physiology-Endocrinology and Metabolism ·Jukka Kero,Eriika Savontaus,(unknown),Ullamari Pesonen,Markku Koulu,Ruth A. Keri,John H. Nilson,Matti Poutanen,Ilpo Huhtaniemi	22
18	Transgenic Mice with Chronically Elevated Luteinizing Hormone Are Infertile Due to Anovulation, Defects in Uterine Receptivity, and Midgestation Pregnancy Failure¹ 1999 ·Endocrinology ·Rachel J. Mann,Ruth A. Keri,John H. Nilson	34
19	Implementing Transgenic and Embryonic Stem Cell Technology to Study Gene Expression, Cell-Cell Interactions and Gene Function 1995 ·Biology of Reproduction ·Sally A. Camper,Thomas L. Saunders,Susan Kendall,Ruth A. Keri,Audrey F. Seasholtz,(unknown),(unknown),Catherine E. Keegan,I Károlyi,(unknown),Heather L. Burrows,Linda C. Samuelson	36
20	Estradiol Inhibits Transcription of the Human Glycoprotein Hormone α-Subunit Gene Despite the Absence of a High Affinity Binding Site for Estrogen Receptor 1991 ·Molecular Endocrinology ·Ruth A. Keri,Bogi Andersen,Giulia C. Kennedy,Debora L. Hamernik,Colin M. Clay,(unknown),Terry M. Nett,Angelο C. Notides,John H. Nilson	57

About Ruth A. Keri

Ruth A. Keri is a scholar working on Reproductive Medicine, Oncology and Immunology and Allergy, having authored 92 papers that have together received 4.3k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (14 papers), Ubiquitin and proteasome pathways (9 papers) and Animal Genetics and Reproduction (9 papers). The work is most often cited by research in Reproductive Medicine (449 citations), Cancer Research (673 citations) and Health, Toxicology and Mutagenesis (530 citations). Ruth A. Keri has collaborated with scholars based in United States, Australia and Finland. Frequent co-authors include John H. Nilson, Darcie D. Seachrist, Gail S. Prins, Shuk‐Mei Ho, Ana M. Soto, Fadi W. Abdul‐Karim, Kristen L. Lozada, Steven T. Sizemore, Jonathan D. Mosley and Emhonta Johnson. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact